Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
235
-
Total 13F shares, excl. options
-
56,959,606
-
Shares change
-
-424,903
-
Total reported value, excl. options
-
$1,570,365,603
-
Value change
-
-$13,068,601
-
Put/Call ratio
-
8.6%
-
Number of buys
-
100
-
Number of sells
-
120
-
Price
-
$27.57
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2023
As of 30 Sep 2023 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,959,606 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, LOOMIS SAYLES & CO L P, Stephens Investment Management Group LLC, Polar Capital Holdings Plc, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 235 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.